Chris Dunne
Corporate Officer/Principal chez NOVAVAX, INC.
Profil
Chris Dunne is currently working as the Vice President-Finance at Novavax, Inc. He previously worked as the Senior Director-Finance at Ore Pharmaceuticals, Inc. from 1996 to 2010.
He completed his undergraduate degree from the University of Maryland.
Postes actifs de Chris Dunne
| Sociétés | Poste | Début |
|---|---|---|
| NOVAVAX, INC. | Corporate Officer/Principal | 01/01/2010 |
Anciens postes connus de Chris Dunne
| Sociétés | Poste | Fin |
|---|---|---|
Ore Pharmaceuticals, Inc.
 Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Corporate Officer/Principal | 01/01/2010 |
Formation de Chris Dunne
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVAVAX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Health Technology |
